Aprogen Pharmaceuticals Inc. Aprogen pharmaceuticals,Inc., formerly Schnell Biopharmaceuticals, Inc., is a Korea-based company mainly engaged in manufacture and wholesale of pharmaceuticals. The Company provides special pharmaceuticals, such as antibiotics, antifungal agents, antiviral agents, anticancer agents, diabetes treatments, antilipemic agents, antispasmodic, adrenocortical hormones agents, external applications, psychotropic agents and others, and general pharmaceuticals, such as antipyretic analgesics, antihistamine, antitussives, expectorants, antacids, intestinal drugs, vitamin supplements, calcium agents and others. It distributes its products to hospitals, drugstores and clinics.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.